Literature DB >> 28823102

The Etiology of Primary Hyperhidrosis: A Systematic Review.

Moshe Hashmonai1, Alan E P Cameron2, Cliff P Connery3, Noel Perin4, Peter B Licht5.   

Abstract

PURPOSE: Primary hyperhidrosis is a pathological disorder of unknown etiology, affecting 0.6-5% of the population, and causing severe functional and social handicaps. As the etiology is unknown, it is not possible to treat the root cause. Recently some differences between affected and non-affected people have been reported. The aim of this review is to summarize these new etiological data.
METHODS: Search of the literature was performed in the PubMed/Medline Database and pertinent articles were retrieved and reviewed. Additional publications were obtained from the references of these articles.
RESULTS: Some anatomical and pathophysiological characteristics (as well as enzymatic, metabolic, and neurological dysfunctions) have been observed in hyperhidrotic subjects; three main possible etiological factors predominate. A familial trait seems to exist, and genetic loci associated with hyperhidrosis have been identified. Histological differences were observed in sympathetic ganglia of hyperhidrotic subjects: the ganglia were larger and contained a higher number of ganglion cells. A higher expression of acetylcholine and alpha-7 neuronal nicotinic receptor subunit in the sympathetic ganglia of patients with hyperhidrosis has been reported.
CONCLUSIONS: Despite these accumulated data, the etiology of primary hyperhidrosis remains obscure. Nevertheless, three main lines for future research seem to be delineated: genetics, histological observations, and enzymatic studies.

Entities:  

Keywords:  Epidemiology; Etiology; Primary Hyperhidrosis; Sympathetic System

Mesh:

Year:  2017        PMID: 28823102     DOI: 10.1007/s10286-017-0456-0

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  35 in total

1.  Primary palmar hyperhidrosis locus maps to 14q11.2-q13.

Authors:  Ikuyo Higashimoto; Koh-ichiro Yoshiura; Naomi Hirakawa; Ken Higashimoto; Hidenobu Soejima; Tadahide Totoki; Tsunehiro Mukai; Norio Niikawa
Journal:  Am J Med Genet A       Date:  2006-03-15       Impact factor: 2.802

2.  Essential hyperhidrosis: no evidence of abnormal personality features.

Authors:  O S Kwon; B S Kim; K H Cho; J S Kwon; M S Shin; J I Youn; J H Chung
Journal:  Clin Exp Dermatol       Date:  1998-01       Impact factor: 3.470

3.  Palmar hyperhidrosis and its surgical treatment: a report of 100 cases.

Authors:  R Adar; A Kurchin; A Zweig; M Mozes
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

Review 4.  Pathophysiology and Treatment of Hyperhidrosis.

Authors:  Tomoko Fujimoto
Journal:  Curr Probl Dermatol       Date:  2016-08-30

5.  [Histopathological changes in sympathetic ganglia of patients treated surgically for palmar-axillary hyperhidrosis. A study of 55 biopsies].

Authors:  J Moya; R Ramos; J Prat; R Morera; R Bernat; R Villalonga; G Ferrer
Journal:  Arch Bronconeumol       Date:  2003-03       Impact factor: 4.872

6.  Abnormal sympathetic skin response in patients with palmar hyperhidrosis.

Authors:  T K Lin; E C Chee; H J Chen; M H Cheng
Journal:  Muscle Nerve       Date:  1995-08       Impact factor: 3.217

7.  Erythrocyte oxidant/antioxidant status in essential hyperhidrosis.

Authors:  Semsettin Karaca; Mustafa Kulac; Efkan Uz; Hakan Mollaoglu; H Ramazan Yilmaz
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

8.  The secretory clear cell of the eccrine sweat gland as the probable source of excess sweat production in hyperhidrosis.

Authors:  Douglas L Bovell; Alison MacDonald; Barbara A Meyer; Alistair D Corbett; William M MacLaren; Susan L Holmes; Mark Harker
Journal:  Exp Dermatol       Date:  2011-10-13       Impact factor: 3.960

9.  Morphometric analysis of thoracic ganglion neurons in subjects with and without primary palmar hyperhidrosis.

Authors:  Flavio Roberto Garbelini de Oliveira; Nabor B Moura; Jose Ribas M de Campos; Nelson Wolosker; Edwin R Parra; Vera L Capelozzi; Paulo Pêgo-Fernandes
Journal:  Ann Vasc Surg       Date:  2013-12-14       Impact factor: 1.466

Review 10.  Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.

Authors:  Oliver P Kreyden; E Paul Scheidegger
Journal:  Clin Dermatol       Date:  2004 Jan-Feb       Impact factor: 3.541

View more
  6 in total

Review 1.  How to diagnose and measure primary hyperhidrosis: a systematic review of the literature.

Authors:  Kristina S Ibler; Gregor B E Jemec; Mattias A S Henning; Linnea Thorlacius
Journal:  Clin Auton Res       Date:  2021-03-27       Impact factor: 4.435

2.  Microneedling Delivery of Botulinum Toxin Versus Intradermal Injection in the Treatment of Facial Hyperhidrosis.

Authors:  Howyda Ebrahim; Amany Nassar; Mariam Mohammed Mousa; Elsayed Khater
Journal:  J Clin Aesthet Dermatol       Date:  2022-09

3.  Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin.

Authors:  Débora Yumi Ferreira Kamikava; Nelson Wolosker; Marcelo Fiorelli Alexandrino da Silva; José Ribas Milanez de Campos; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2021-06-28       Impact factor: 2.365

4.  Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro.

Authors:  Maria Ribeiro Santos Morard; Ricardo Betanho Martins; Ana Carolina Lopes Ribeiro; Pedro Guimarães Rocha Lima; Beatriz Dos Santos Carvalho; José Carlos Baldelim Santiago Junior
Journal:  PLoS One       Date:  2019-09-13       Impact factor: 3.240

5.  Paeoniflorin inhibits proliferation and promotes autophagy and apoptosis of sweat gland cells.

Authors:  Yuan Xu; Hong He; Ping Li; Hongwei Liu
Journal:  Exp Ther Med       Date:  2021-11-16       Impact factor: 2.447

6.  Antagonist of Chrna1 prevents the pathogenesis of primary focal hyperhidrosis.

Authors:  Jian-Bo Lin; Nan-Long Lin; Xu Li; Ming-Qiang Kang
Journal:  Ann Clin Transl Neurol       Date:  2022-04-08       Impact factor: 5.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.